CRP, Risk Factors and Major Adverse Cardiovascular Events: Insights From ACCELERATE

被引：0
|
作者：
Scherer, Daniel J.
Nicholls, Stephen J.
Lincoff, A. Michael
Menon, Venu
Riesmeyer, Jeffrey S.
Ruotolo, Giacomo
Weerakkody, Govinda J.
Wolski, Kathy
McErlean, Ellen
Nissen, Steven E.
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Inflammation and inflammatory markers; Cardiovascular disease; Risk factors; Clinical trials;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
20126
引用
收藏
页数：2
相关论文
共 50 条
  • [1] GENDER SPECIFIC FACTORS ASSOCIATED WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS: INSIGHTS FROM ACCELERATE
    King, Peta
    Cremer, Paul
    Nicholls, Stephen
    Lincoff, A.
    Menon, Venu
    Riesmeyer, Jeffrey
    Ruotolo, Giacomo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 202 - 202
  • [2] ELEVATED LEVELS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO PREDICTS INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN HIGH RISK PATIENTS: INSIGHTS FROM ACCELERATE
    Nelson, Adam J.
    Nicholls, Stephen
    Lincoff, A.
    Menon, Venu
    Riesmeyer, Jeffrey
    Ruotolo, Giacomo
    Wolski, Kathy
    McErlean, Ellen
    Nissen, Steven
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 33 - 33
  • [3] Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease
    Hageman, Steven H. J.
    de Borst, Gert Jan
    Dorresteijn, Johannes A. N.
    Bots, Michiel L.
    Westerink, Jan
    Asselbergs, Folkert W.
    Visseren, Frank L. J.
    HEART, 2020, 106 (21) : 1686 - 1692
  • [4] MAJOR ADVERSE CARDIOVASCULAR EVENTS: RISK FACTORS IN PATIENTS WITH RA TREATED WITH TOFACITINIB
    Charles-Schoeman, C.
    Valdez, H.
    Soma, K.
    Hwang, L.
    DeMasi, R.
    Boy, M.
    McInnes, I. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1034 - 1035
  • [5] An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy
    Rao, Vijay U.
    Pavlov, Andrey
    Klearman, Micki
    Musselman, David
    Giles, Jon T.
    Bathon, Joan M.
    Sattar, Naveed
    Lee, Janet S.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (02) : 372 - 380
  • [6] Major Adverse Cardiovascular Events: Risk Factors in Patients with RA Treated with Tofacitinib
    Charles-Schoeman, Christina
    Valdez, Hernan
    Soma, Koshika
    Hwang, Lie-Ju
    DeMasi, Ryan
    Boy, Mary
    McInnes, Iain B.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study
    Noumegni, Steve Raoul
    Didier, Romain
    Mansourati, Vincent
    Le Moigne, Emmanuelle
    Le Mao, Raphael
    Hoffmann, Clement
    Moreuil, Claire De
    Tromeur, Cecile
    Le Roux, Pierre-Yves
    Nasr, Bahaa
    Gentric, Jean-Christophe
    Guegan, Marie
    Poulhazan, Elise
    Lacut, Karine
    Bressollette, Luc
    Couturaud, Francis
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (04): : 465 - 480
  • [8] Accelerated development of cardiovascular risk factors mediates risk for major adverse cardiovascular events in posttraumatic stress disorder
    Khalil, Maria
    Sinnott, Sinead M.
    Civieri, Giovanni
    Abohashem, Shady
    Grewal, Simran S.
    Hanlon, Erin
    Assefa, Alula
    Qamar, Iqra
    Lau, Hui Chong
    Karam, Krystel Abi
    Aldosoky, Wesam
    Shin, Lisa M.
    Tawakol, Ahmed
    Seligowski, Antonia V.
    Osborne, Michael T.
    BRAIN BEHAVIOR AND IMMUNITY, 2025, 125 : 148 - 157
  • [9] JAK inhibitors: risk of major adverse cardiovascular events
    Reactions Weekly, 2025, 2052 (1) : 8 - 8
  • [10] Prediabetes as a risk factor for major adverse cardiovascular events
    Mando, Ramy
    Waheed, Muhammad
    Michel, Adrian
    Karabon, Patrick
    Halalau, Alexandra
    ANNALS OF MEDICINE, 2021, 53 (01) : 2090 - 2098
12345